Clinicians with obligations to patients and to organizations often assess patients in law enforcement for both therapeutic and nontherapeutic purposes.
AMA J Ethics. 2022;24(2):E111-119. doi:
10.1001/amajethics.2022.111.
When police officers and clinicians perceive a moral transgression committed by an agent responding to risk in the field, they are susceptible to moral injury.
AMA J Ethics. 2022;24(2):E126-132. doi:
10.1001/amajethics.2022.126.
Critical race theory tools of evaluating stock characters and counter stories can help clinicians and researchers illuminate experiences of those at the margins.
AMA J Ethics. 2022;24(3):E212-217. doi:
10.1001/amajethics.2022.212.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Physicians can improve diets of patients who live in food deserts by providing nutrition materials, training in food preparation, and promoting nutritious food availability in communities where they practice.
AMA J Ethics. 2018;20(10):E918-923. doi:
10.1001/amajethics.2018.918.